ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
2018 · Nature Communications · 218 citations
https://doi.org/10.1038/s41467-018-06498-2
K
Kenneth Robzyk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
2.2K
Citations
13
h-index
15
i10-index
Kenneth Robzyk is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Lung Cancer Research Studies & Fungal and yeast genetics research. The author has an h-index of 13, co-authored 31 publications.
Papers by this author
worksInduction of Meiosis in <i>Saccharomyces cerevisiae</i> Depends on Conversion of the Transcriptional Repressor Ume6 to a Positive Regulator by Its Regulated Association with the Transcriptional Activator Ime1
1996 · Molecular and Cellular Biology · 141 citations
https://doi.org/10.1128/mcb.16.5.2518
Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids
2019 · Cancer Research · 79 citations
https://doi.org/10.1158/0008-5472.can-19-0214
Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression
2019 · Molecular Cancer · 61 citations
https://doi.org/10.1186/s12943-019-1018-y
Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone
2020 · Cell Reports · 59 citations
https://doi.org/10.1016/j.celrep.2020.107840
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat